Correction to: Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities.

Tanaka, Norina; Imai, Yoichi; Yoshinaga, Kentaro; Shiseki, Masayuki; Tanaka, Junji

Tanaka, Norina; Imai, Yoichi; Yoshinaga, Kentaro; Shiseki, Masayuki; Tanaka, Junji.

Afiliação

Tanaka N; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
Imai Y; Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan. imaiyo-tky@umin.ac.jp.
Yoshinaga K; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
Shiseki M; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
Tanaka J; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.

Ann Hematol ; 99(11): 2587, 2020 Nov.

Article em En | MEDLINE | ID: mdl-32980889

ABSTRACT

ABSTRACT

In the published online paper, the data "p = 0.144" was not deleted from the line "Median and mean number of prior treatments (range)" in Table 4.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article